The new product contains SGLT2 inhibitor empagliflozin, the active ingredient in Jardiance, along with DPP4 inhibitor linagliptin (sold as Tradjenta in the US) and generic diabetes drug metformin ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback